Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
931 | 2952 | 30.0 | 70% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
6 | 4 | GASTROENTEROLOGY & HEPATOLOGY//ONCOLOGY//SURGERY | 1371034 |
174 | 3 | RADIAT ONCOL//MEDICAL PHYSICS//HEAD AND NECK CANCER | 58342 |
242 | 2 | HEAD AND NECK CANCER//ORAL CANCER//ORAL ONCOLOGY | 20011 |
931 | 1 | HEAD AND NECK CANCER//INDUCTION CHEMOTHERAPY//LARYNX PRESERVATION | 2952 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | HEAD AND NECK CANCER | authKW | 678618 | 22% | 10% | 655 |
2 | INDUCTION CHEMOTHERAPY | authKW | 627200 | 6% | 34% | 181 |
3 | LARYNX PRESERVATION | authKW | 277030 | 2% | 56% | 48 |
4 | LOCALLY ADVANCED HEAD AND NECK CANCER | authKW | 212745 | 1% | 86% | 24 |
5 | ALTERED FRACTIONATION | authKW | 139768 | 1% | 48% | 28 |
6 | TPF | authKW | 133432 | 1% | 65% | 20 |
7 | CHEMORADIOTHERAPY | authKW | 129965 | 5% | 8% | 161 |
8 | HEAD AND NECK CARCINOMA | authKW | 115465 | 2% | 18% | 61 |
9 | ACCELERATED RADIOTHERAPY | authKW | 113816 | 1% | 32% | 34 |
10 | ACCELERATED FRACTIONATION | authKW | 112580 | 1% | 39% | 28 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Oncology | 54435 | 69% | 0% | 2042 |
2 | Otorhinolaryngology | 22824 | 19% | 0% | 554 |
3 | Radiology, Nuclear Medicine & Medical Imaging | 5646 | 18% | 0% | 525 |
4 | Surgery | 996 | 12% | 0% | 350 |
5 | Dentistry, Oral Surgery & Medicine | 669 | 4% | 0% | 127 |
6 | Medicine, Research & Experimental | 54 | 3% | 0% | 84 |
7 | Pharmacology & Pharmacy | 22 | 5% | 0% | 133 |
8 | Medicine, General & Internal | 17 | 3% | 0% | 88 |
9 | Neuroimaging | 3 | 0% | 0% | 8 |
10 | Hematology | 1 | 1% | 0% | 32 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | RADIAT ONCOL | 66511 | 22% | 1% | 649 |
2 | HEAD NECK ONCOL PROGRAM | 52108 | 1% | 23% | 22 |
3 | HEAD NECK SURG | 43825 | 5% | 3% | 153 |
4 | CLIN ONCOL RADIOTHER IE | 38067 | 0% | 41% | 9 |
5 | LUDWIG BOLTZMANN GEROSTOMATOL | 31026 | 0% | 100% | 3 |
6 | AMBULANZZENTRUM BEREICH STRAHLENTHER IE | 23268 | 0% | 75% | 3 |
7 | HEAD NECK CANC ULM | 23268 | 0% | 75% | 3 |
8 | KOPF HALS CHIRURG ONKOL | 23268 | 0% | 75% | 3 |
9 | MED ONCOL INTERNAL MED SCI | 23268 | 0% | 75% | 3 |
10 | MED ONCOL | 22197 | 11% | 1% | 318 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK | 37286 | 4% | 3% | 132 |
2 | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 28828 | 7% | 1% | 220 |
3 | AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS | 27113 | 3% | 3% | 103 |
4 | ORAL ONCOLOGY | 20773 | 3% | 3% | 78 |
5 | RADIOTHERAPY AND ONCOLOGY | 18329 | 3% | 2% | 103 |
6 | STRAHLENTHERAPIE UND ONKOLOGIE | 17665 | 2% | 3% | 65 |
7 | JOURNAL OF CLINICAL ONCOLOGY | 12001 | 5% | 1% | 138 |
8 | CANCER | 9672 | 5% | 1% | 162 |
9 | HEAD & NECK SURGERY | 9325 | 1% | 4% | 21 |
10 | SEMINARS IN ONCOLOGY | 9089 | 2% | 1% | 68 |
Author Key Words |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | HEAD AND NECK CANCER | 678618 | 22% | 10% | 655 | Search HEAD+AND+NECK+CANCER | Search HEAD+AND+NECK+CANCER |
2 | INDUCTION CHEMOTHERAPY | 627200 | 6% | 34% | 181 | Search INDUCTION+CHEMOTHERAPY | Search INDUCTION+CHEMOTHERAPY |
3 | LARYNX PRESERVATION | 277030 | 2% | 56% | 48 | Search LARYNX+PRESERVATION | Search LARYNX+PRESERVATION |
4 | LOCALLY ADVANCED HEAD AND NECK CANCER | 212745 | 1% | 86% | 24 | Search LOCALLY+ADVANCED+HEAD+AND+NECK+CANCER | Search LOCALLY+ADVANCED+HEAD+AND+NECK+CANCER |
5 | ALTERED FRACTIONATION | 139768 | 1% | 48% | 28 | Search ALTERED+FRACTIONATION | Search ALTERED+FRACTIONATION |
6 | TPF | 133432 | 1% | 65% | 20 | Search TPF | Search TPF |
7 | CHEMORADIOTHERAPY | 129965 | 5% | 8% | 161 | Search CHEMORADIOTHERAPY | Search CHEMORADIOTHERAPY |
8 | HEAD AND NECK CARCINOMA | 115465 | 2% | 18% | 61 | Search HEAD+AND+NECK+CARCINOMA | Search HEAD+AND+NECK+CARCINOMA |
9 | ACCELERATED RADIOTHERAPY | 113816 | 1% | 32% | 34 | Search ACCELERATED+RADIOTHERAPY | Search ACCELERATED+RADIOTHERAPY |
10 | ACCELERATED FRACTIONATION | 112580 | 1% | 39% | 28 | Search ACCELERATED+FRACTIONATION | Search ACCELERATED+FRACTIONATION |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | FURNESS, S , GLENNY, AM , WORTHINGTON, HV , PAVITT, S , OLIVER, R , CLARKSON, JE , MACLUSKEY, M , CHAN, KKW , CONWAY, DI , (2011) INTERVENTIONS FOR THE TREATMENT OF ORAL CAVITY AND OROPHARYNGEAL CANCER: CHEMOTHERAPY.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 4. P. - | 166 | 74% | 13 |
2 | FURNESS, S , GLENNY, AM , WORTHINGTON, HV , PAVITT, S , OLIVER, R , CLARKSON, JE , MACLUSKEY, M , CHAN, KKW , CONWAY, DI , (2010) INTERVENTIONS FOR THE TREATMENT OF ORAL CAVITY AND OROPHARYNGEAL CANCER: CHEMOTHERAPY.COCHRANE DATABASE OF SYSTEMATIC REVIEWS. VOL. . ISSUE 9. P. - | 158 | 74% | 10 |
3 | ADELSTEIN, DJ , (2003) SYSTEMIC CHEMOTHERAPY FOR SQUAMOUS CELL HEAD AND NECK CANCER.EXPERT OPINION ON PHARMACOTHERAPY. VOL. 4. ISSUE 12. P. 2151-2163 | 90 | 96% | 14 |
4 | MICHIELS, S , LE MAITRE, A , BUYSE, M , BURZYKOWSKI, T , MAILLARD, E , BOGAERTS, J , VERMORKEN, JB , BUDACH, W , PAJAK, TF , ANG, KK , ET AL (2009) SURROGATE ENDPOINTS FOR OVERALL SURVIVAL IN LOCALLY ADVANCED HEAD AND NECK CANCER: META-ANALYSES OF INDIVIDUAL PATIENT DATA.LANCET ONCOLOGY. VOL. 10. ISSUE 4. P. 341 -350 | 73 | 88% | 50 |
5 | ARGIRIS, A , JAYARAM, P , PICHARDO, D , (2005) REVISITING INDUCTION CHEMOTHERAPY FOR HEAD AND NECK CANCER - REFERENCES AND REVIEWS.ONCOLOGY-NEW YORK. VOL. 19. ISSUE 7. P. 932-+ | 81 | 88% | 4 |
6 | SPECENIER, PM , VERMORKEN, JB , (2009) CURRENT CONCEPTS FOR THE MANAGEMENT OF HEAD AND NECK CANCER: CHEMOTHERAPY.ORAL ONCOLOGY. VOL. 45. ISSUE 4-5. P. 409 -415 | 60 | 94% | 35 |
7 | SPECENIER, PM , VERMORKEN, JB , (2007) NEOADJUVANT CHEMOTHERAPY IN HEAD AND NECK CANCER: SHOULD IT BE REVISITED?.CANCER LETTERS. VOL. 256. ISSUE 2. P. 166-177 | 62 | 87% | 17 |
8 | HUGHES, RS , FRENKEL, EP , (1997) THE ROLE OF CHEMOTHERAPY IN HEAD AND NECK CANCER.AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS. VOL. 20. ISSUE 5. P. 449-461 | 75 | 93% | 18 |
9 | STROJAN, P , VERMORKEN, JB , BEITLER, JJ , SABA, NF , HAIGENTZ, M , BOSSI, P , WORDEN, FP , LANGENDIJK, JA , EISBRUCH, A , MENDENHALL, WM , ET AL (2016) CUMULATIVE CISPLATIN DOSE IN CONCURRENT CHEMORADIOTHERAPY FOR HEAD AND NECK CANCER: A SYSTEMATIC REVIEW.HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK. VOL. 38. ISSUE . P. E2151 -E2158 | 36 | 82% | 6 |
10 | MISIUKIEWICZ, K , GUPTA, V , BAKST, R , POSNER, M , (2014) TAXANES IN CANCER OF THE HEAD AND NECK.ANTI-CANCER DRUGS. VOL. 25. ISSUE 5. P. 561 -570 | 51 | 80% | 7 |
Classes with closest relation at Level 1 |